An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

Journal of Psychiatric Practice

Volumn 14, Issue 5, 2008, Pages 271-280

  Leuchter, Andrew F ^a,i   Lesser, Ira M ^b   Trivedi, Madhukar H ^c   Rush, A John ^c   Morris, David W ^c   Warden, Diane ^c   Fava, Maurizio ^d   Wisniewski, Stephen R ^e   Luther, James F ^e   Perales, Mercedes ^f   Gaynes, Bradley N ^g   Stewart, Jonathan W ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF KANSAS   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adverse events; Bupropion; Escitalopram; Major depressive disorder; Medication combinations

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL DISCOMFORT; ADULT; AGED; AKATHISIA; ALLERGY; AMNESIA; APATHY; APPETITE; ARTICLE; BLURRED VISION; BRUXISM; CONSTIPATION; COORDINATION DISORDER; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FLUID RETENTION; HAIR LOSS; HEADACHE; HEARING DISORDER; HOT FLUSH; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENSTRUATION DISORDER; MICTURITION DISORDER; MONOTHERAPY; MUSCLE CRAMP; MUSCLE TWITCH; NAUSEA; NIGHTMARE; ORGASM; OUTPATIENT; PARESTHESIA; PILOT STUDY; PULSE RATE; RASH; REMISSION; RIGIDITY; SALIVATION; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SLURRED SPEECH; SWEATING; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER; THORAX PAIN; TINNITUS; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; URINARY FREQUENCY; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA; ADOLESCENT; AMBULATORY CARE; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CITALOPRAM; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 62249157100     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000336754.19566.65     Document Type: Article

References (28)

1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
2. Trivedi MH, Rush AJ,Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: Implications for clinical practice. Am J Psychiatry 2006;163:28-40.
3. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354:1243-52.
4. Warden D, Trivedi MH, Wisniewski SR, et al. Predictors of attrition during initial (citalopram) treatment for depression: A STAR*D report. Am J Psychiatry 2007;164:1189-97.
5. Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003;64(Suppl)13:13-7.
6. Mischoulon D, Nierenberg AA, Kizilbash L, et al. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians. Can J Psychiatry 2000;45:476-81.
7. Fava M, Kendler KS. Major depressive disorder. Neuron 2000;28:335-41.
8. Zisook S, Rush AJ, Haight BR, et al. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 2006;59:203-10.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
10. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33.
11. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-83.
12. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 2004;34:73-82.
13. Unützer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA 2002;288:2836-45.
14. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995;273:1026-31.
15. Rush AJ, Trivedi MH, Carmody TJ, et al. Self-reported depressive symptom measures: Sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology 2005;30:405-16.
16. Wisniewski SR, Rush AJ, Balasubramani GK, et al. Self-rated global measure of the frequency, intensity and burden of medication side effects. J Psychiatr Pract 2006;12:71-9.
17. Moynihan C. Instruction manual for Systematic Assessment for Treatment Emergent Events (SAFTEE). Rockville, MD: Alcohol, Drug Abuse, and Mental Health Administration; 1983.
18. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-6.
19. Munetz MR, Benjamin S. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Community Psychiatry 1998;39:1172-7.
20. Trivedi MH, Stegman D, Rush AJ, et al. STAR*D Clinical Procedures Manual, July 31, 2002 (can be accessed at www.edc.pitt.edu/stard/public/study- manuals.html).
21. Depression Guideline Panel. Clinical practice guideline, number 5: Depression in primary care: Volume 2. Treatment of major depression. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. 1993.
22. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
23. DeBattista C, Solvason B, Poirier J, et al. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol 2003; 23:27-30.
24. Lam RW, Hossie H, Solomons K, et al. Citalopram and bupropion-SR: Combining versus switching in patients with treatment-resistant depression. J Clin Psychiatry 2004;65:337-40.
25. Ramasubbu R. Treatment of resistant depression by adding noradrenergic agents to lithium augmentation of SSRIs. Ann Pharmacother 2002;36:634-40.
26. Bodkin JA, Lasser RA, Wines JD, et al. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997;58: 137-45.
27. Spier SA. Use of bupropion with SRIs and venlafaxine. Depress Anxiety 1998;7:73-5.
28. Whyte EM, Basinski J, Farhi P, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004;65:1634-41.